The purpose was to compare the changes in claudication pain, ambulatory function, daily physical activity, peripheral circulation, and health-related quality of life following a program of exercise rehabilitation in smoking and nonsmoking patients with peripheral arterial disease (PAD) limited by intermittent claudication. Methods and results: Thirty-nine smokers (63 ؎ 4 pack-year smoking history; mean ؎ SE) and 46 nonsmokers (former smokers who had a 51 ؎ 7 pack-year smoking history who quit 14 ؎ 2 years prior to investigation) completed the study. The 6-month exercise rehabilitation program consisted of intermittent treadmill walking to near maximal claudication pain 3 days per week, with progressive increases in walking duration and intensity during the program. Measurements were obtained on each patient before and after rehabilitation. Following exercise rehabilitation the smokers and nonsmokers had similar improvements in these measures, as initial claudication distance increased by 119% in the smokers (P < .001) and by 97% in the nonsmokers (P < .001), and absolute claudication distance increased by 82% (P < .001) and 59% (P < .001) in the smokers and nonsmokers, respectively. Furthermore, exercise rehabilitation improved (P < .05) ambulatory function, daily physical activity, peripheral circulation, and health-related quality of life in the smokers and nonsmokers. 
Peripheral arterial disease (PAD) is a leading cause of morbidity as a result of ambulatory dysfunction associated with intermittent claudication. 1 Intermittent claudication afflicts 5% of the US population older than 55 years, 2 thereby limiting daily physical activities 3 and negatively affecting quality of life 4 in many older adults. A primary therapeutic goal for patients with PAD with intermittent claudication is to regain lost physical function through exercise rehabilitation. 5 Medically supervised exercise programs have been studied extensively over the past 35 years and are effective for the clinical management of intermittent claudication. 6 Specifically, exercise rehabilitation improves initial claudication distance (ICD), absolute claudication distance (ACD), measured and perceived ambulatory function, physical activity level, quality of life, and calf blood flow in patients with PAD limited by intermittent claudication. [6] [7] [8] [9] [10] [11] [12] [13] [14] Cigarette smoking is commonly reported in patients with PAD, 15 having both long-term and short-term affects on arterial blood flow in the lower extremities. For example, cigarette smoking is a primary risk factor for development and progression of PAD 16 and causes lingering impairments in peripheral blood flow and oxygen delivery to the lower-extremity musculature following acute exposure to smoking. 17, 18 It is, therefore, not surprising that patients with PAD who currently smoke have more severe claudication, as well as lower exercise capacity, peripheral circulation, and physical activity levels than their nonsmoking counterparts. 19, 20 Consequently, patients with PAD who smoke are on the lower end of the physical function spectrum and may be prime candidates to regain lost functional independence through a program of exercise rehabilitation.
The purpose of this study was to compare the changes in claudication pain, ambulatory function, physical activity level, peripheral circulation, and health-related quality of life following a program of exercise rehabilitation in current smoking and nonsmoking patients with PAD limited by intermittent claudication.
METHODS

Patients
Screening. A total of 106 patients with PAD limited by intermittent claudication were enrolled into an intervention development study and several pilot studies as part of the University of Maryland Claude D. Pepper Older Americans Independence Center. The patients were recruited from the Vascular Clinic at the Baltimore location of the Maryland Veterans Affairs Health Care System (MVAHCS), and from newspaper and radio advertisements in Baltimore. All patients underwent a physical examination during the first baseline visit and were classified as having Fontaine stage II PAD 21 defined by the following inclusion criteria: (1) a positive Rose questionnaire for intermittent claudication, 22 (2) intermittent claudication elicited during a screening treadmill test, and (3) an ankle/ brachial index (ABI) at rest Ͻ0.97. 23 Patients were excluded from this study for the following conditions: (1) absence of PAD; (2) asymptomatic PAD (Fontaine stage I); (3) rest pain PAD (Fontaine stage III); (4) exercise tolerance limited by factors other than claudication (eg, coronary artery disease, dyspnea, poorly controlled blood pressure); and (5) active cancer, renal disease, or liver disease. All patients lived independently at home. The Institutional Review Boards at the University of Maryland and the MVAHCS at Baltimore approved the procedures used in this study. Written informed consent was obtained from each subject prior to investigation.
Smoking status. A smoking history was obtained, and patients were classified as either current smokers (n ϭ 50) or nonsmokers (n ϭ 56), defined as not having smoked over the preceding year. All of those patients included in the nonsmoking group reported a previous history of smoking. The average number of cigarette packs smoked per day and the total number of years of smoking were recorded to determine the pack-year history of the patients. Additionally, the number of years that the nonsmokers had quit smoking was recorded. Smoking status was confirmed at baseline and throughout the study by having the patients breathe into a 2000 Series Ecolyzer carbon monoxide analyzer (National Draeger, Inc, Pittsburgh, Pa) to assess the concentration of carbon monoxide in the expired air.
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Exercise rehabilitation
The exercise rehabilitation program consisted of 6 months of supervised, intermittent treadmill walking to near maximal claudication pain three days per week as previously described. [7] [8] [9] There were no complications during the exercise training sessions. Ten patients from the nonsmoking group and 11 patients from the smoking group withdrew soon after beginning the exercise rehabilitation program. The remaining 46 nonsmokers and 39 smokers completed the exercise intervention and posttreatment measures and, therefore, comprise the sample for the final analyses. Both groups were assessed on the following measurements before and after the exercise rehabilitation program.
Measurements
Medical history. Demographic information, cardiovascular risk factors, comorbidites, and self-reported claudication history were obtained during a medical history interview to begin the evaluation.
Claudication distances and peak oxygen uptake. Patients performed a progressive, graded treadmill protocol (2 mph, 0% grade with 2% increase every 2 minutes) until maximal claudication pain as previously described. 24 The ICD, ACD, time to relief of claudication pain after the test, and peak oxygen uptake were measured. Because handrail support impairs the reliability of claudication pain measurements, 25 patients were only allowed to touch the treadmill handrail for brief moments during the test to maintain balance.
Walking economy. Oxygen uptake was measured during a constant, submaximal work rate at a treadmill speed of 2 mph and a grade of 0% until maximal claudication pain, or for a maximum of 20 minutes. 26 Because the duration of submaximal exercise affects oxygen uptake, we compared the oxygen uptake of each patient at the same time point before and after the study. 26 Consequently, walking economy was measured as the oxygen uptake during the final minute of walking at baseline and at the same time point during the posttest.
Six-minute walk test: Patients performed an over ground, 6-minute walk test supervised by trained exercise technicians as previously described. 27 The pain-free and total distance walked during the test were recorded.
Walking impairment questionnaire (WIQ). Self-reported ambulatory ability was assessed using a validated questionnaire for patients with PAD that assesses ability to walk at various speeds and distances and to climb stairs.
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Daily physical activity. Physical activity level was monitored over 2 consecutive weekdays by a Caltrac accelerometer (Muscle Dynamics, Torrance, Calif) attached to the belt of each subject as previously described. 29 The accelerometer assessed daily physical movements by converting vertical accelerations of the body into caloric expenditure during the 48-hour monitoring period. 30, 31 ABI and ischemic window. As previously described, ABI was obtained from the more severely diseased lower extremity by the Doppler ultrasound technique before and 1, 3, 5, and 7 minutes after the progressive, graded treadmill test used to assess claudication distances and peak oxygen uptake. 24 The reduction in ankle systolic blood pressure following the treadmill test from the resting value was quantified by calculating the area under the curve, referred to as the ischemic window. 32 To assess the change in the ischemic window following exercise rehabilitation, patients performed an additional progressive, graded treadmill test at follow-up but were stopped when they achieved the same walking distance as was measured at baseline. This technique permitted comparison of the change in the ischemic window for a given walking distance before and after exercise rehabilitation, as described by Carter et al. 33 Calf blood flow. Calf blood flow was obtained under resting, reactive hyperemic, and maximal hyperemic conditions in the more severely diseased leg using venous occlusion mercury strain-gauge plethysmography as previously described. 10, [34] [35] [36] [37] Quality of life. Health-related quality of life was assessed with the Medical Outcomes Study Short-Form 36 (MOS SF-36) General Health Survey. 38 The MOS SF-36 is a reliable and valid generic instrument which includes multi-item scales that measure the following eight health domains: physical function, role limitations because of physical problems, general health, bodily pain, social function, role limitations because of emotional problems, mental health, and vitality. For each subscale, item scores were recorded, summed, and standardized into a scale from 0 to 100, with better health states resulting in higher scores.
Statistical analyses
Comparing current smoking and nonsmoking groups of patients with intermittent claudication was an a priori specific aim of the Intervention Development Study of the University of Maryland Pepper Center. Unpaired t tests and chi square tests were used to assess whether differences in baseline clinical characteristics existed between the smokers and nonsmokers. A series of one-factor (group; smokers versus nonsmokers) analyses of covariance (ANCOVA) were used to compare the changes in the functional, physiologic, and quality of life variables between the smoking and nonsmoking patients having both pretest and posttest data points. The dependent variable in each of the ANCOVAs was the within-person difference (posttest minus pretest) in the variable being analyzed. The initial value of the dependent variable was included as an independent covariate to adjust for the difference in its initial value. On the basis of previous studies, 7-9 the sample sizes of the smoking and nonsmoking groups yielded statistical power estimates of greater than 90% to detect exercise-mediated changes in ICD and ACD and greater than 70% to detect changes in most of the other measurements. Pearson product-moment correlation coefficients (r) were calculated to determine the association between the change in variables following exercise rehabilitation. Statistical significance was set at P Ͻ .05. Measurements are presented as means Ϯ standard errors.
RESULTS
Similar baseline clinical characteristics were found between the two groups ( Table I ), except that the smoking group had smoked cigarettes for 11 additional years (P Ͻ .05) and had a higher pack-year history (P Ͻ .05) than the nonsmoking patients who, on average, had quit smoking 14 years prior to investigation. Smoking did not affect the adherence to the exercise rehabilitation program, as the average attendance was similar (P Ͼ .05) between the smoking group (73% Ϯ 4%), and the nonsmoking group (77% Ϯ 4%). Furthermore, the smoking group had no change (P Ͼ .05) in cigarette consumption before (1.4 Ϯ 0.1 packs/day) and after (1.3 Ϯ 0.1 packs/day) the exercise rehabilitation program.
The treadmill measures shown in Table II indicate that the smoking group had significantly lower (P Ͻ .05) ICD, ACD, and peak oxygen uptake than the nonsmoking group at baseline, whereas the time to relief of claudication pain and walking economy were similar (P Ͼ .05). Both groups demonstrated a significant (P Ͻ .05) and similar improvement in ICD, ACD, peak oxygen uptake, and walking economy following exercise rehabilitation. Neither group had a significant (P Ͼ .05) change in the time to relief of claudication pain following the exercise program.
The ambulatory and physical activity measures shown in Table III indicate that the smoking group had significantly lower (P Ͻ .05) baseline values on all variables compared with the nonsmoking group. Both groups had a significant (P Ͻ .05) and similar improvement in the painfree and total walking distances during the 6-minute walk test, WIQ distance score, and daily physical activity following exercise rehabilitation. However, only the smokers had a significant (P Ͻ .05) improvement in the WIQ speed score and the WIQ stair climbing score.
The peripheral hemodynamic measurements displayed in Table IV indicate that the smoking group had significantly lower (P Ͻ .05) calf blood flow under resting, reactive hyperemic, and maximal hyperemic conditions than the nonsmoking group at baseline, whereas ABI and ischemic window were similar (P Ͼ .05). Both groups had a significant (P Ͻ .05) and similar improvement in the calf blood flow measures and in the ischemic window following exercise rehabilitation. However, the calf blood flow measures in the smoking group remained lower (P Ͻ .05) than the nonsmoking group during follow-up. Neither group had a significant (P Ͼ .05) change in ABI following the exercise program. As a result of similar vascular changes following exercise rehabilitation between the groups, we pooled the smokers and nonsmokers to assess whether the change in claudication distances following exercise rehabilitation was related to the change in perfusion of the lower extremity. The change in ICD was correlated with the change in the ischemic window (r ϭ Ϫ0.29, P Ͻ .05), and with the change in calf blood flow under reactive hyperemic (r ϭ 0.39, P Ͻ .001), and maximal hyperemic (r ϭ 0.44, P Ͻ .001) conditions. Similarly, the change in ACD was correlated with the change in the ischemic window (r ϭ Ϫ0.33, P Ͻ .05), and with the change in calf blood flow under reactive hyperemic (r ϭ 0.41, P Ͻ .001), and maximal hyperemic (r ϭ 0.44, P Ͻ .001) conditions. Similar results were found when these analyses were performed within each group. The health-related quality of life measures shown in Table V indicate that the smoking group had significantly lower (P Ͻ .05) scores on bodily pain, general health, mental health, and vitality than the nonsmoking group at baseline, whereas the remaining variables were similar (P Ͼ .05). Both groups had a significant (P Ͻ .05) and similar improvement in physical function and bodily pain following exercise rehabilitation. None of the other health domains changed (P Ͼ .05) following exercise in either group.
DISCUSSION
The major findings of this investigation were (1) smokers had greater impairments in claudication pain distances, ambulatory function, physical activity, peripheral circulation, and health-related quality of life than nonsmokers at baseline and (2) both groups had similar improvements in these measures following a 6-month exercise rehabilitation program.
Baseline comparisons between smokers and nonsmokers. As expected, the smokers had a 24% greater pack-year history of smoking at baseline than the nonsmokers, because of 11 more years of smoking. However, the two groups were similar on other clinical characteristics such as age, claudication history, cardiovascular risk factors, comorbid conditions, proportion of men and women, and proportion of Caucasians and African Americans. Consequently, baseline differences in claudication distances, ambulatory function, physical activity level, peripheral circulation, and health-related quality of life can be attributed to the greater exposure of cigarette smoking rather than to a more complicated medical history.
The smokers were more limited by intermittent claudication than were the nonsmokers, as their ICD and ACD were shorter by 39 meters (20%) and by 65 meters (15%), respectively. This finding supports previous observations of a 17% shorter ICD and a 20% shorter ACD in current smokers compared with former smokers, 19 and a 38% shorter ICD and a 35% shorter ACD in current smokers compared with patients with PAD who had never smoked. 39 Not surprisingly, the more rapid development of claudication pain in the smokers resulted in an 8% lower peak oxygen uptake than the smokers, supporting previous findings of a 7% lower peak oxygen uptake in current smokers compared with former smokers, 19 and a 15% lower peak oxygen uptake in current smokers compared with Values are means (SEM). *Significant difference between groups (P Ͻ .05). † Significant change from the pretest (P Ͻ .05).
JOURNAL OF VASCULAR SURGERY Volume 39, Number 3 patients with PAD who had never smoked. 39 The impaired treadmill performance of the smokers translated into worse ambulatory function during the 6-minute walk test, as the pain-free distance and total walking distance were 20% and 9% lower than the nonsmokers, respectively. The negative effect of cigarette smoking on 6-minute walk performance in patients with PAD has been documented in previous work from our laboratory, [39] [40] [41] suggesting that current smoking places further limitations on an over ground walking task that closely resembles community-based walking. This point is underscored by noting that the smokers had a worse perception in their ability to walk various distances and speeds and to climb stairs than their nonsmoking counterparts, possibly contributing to their lower daily physical activity in the community setting. Previous work from our laboratory supports the detrimental influence of cigarette smoking on both perceived ambulatory function [39] [40] [41] and on daily physical activity. 20, [39] [40] [41] Interestingly, the lower baseline functional status of the smokers negatively affected their quality of life in both physical and mental health domains compared with the nonsmoking patients with PAD.
The smokers had a lower calf blood flow than the nonsmokers under resting, reactive hyperemic, and maximal hyperemic conditions despite having similar severity of PAD as measured by ABI and ischemic window values. This finding supports previous studies 20, 39, 41 and suggests that cigarette smoking results in peripheral vasoconstriction in the lower extremities. 17 Furthermore, the greater impairment in perfusion of the calf musculature in the smokers at baseline is a potential explanation for their lower claudication distances and overall physical function than in the nonsmoking patients. 20, 41 Responses to exercise rehabilitation in smokers and nonsmokers. Adherence to the exercise rehabilitation program was similar between the smokers and nonsmokers, as both groups attended approximately 75% of the possible exercise training sessions. This finding is similar to the exercise attendance reported in a previous randomized, controlled exercise trial from our laboratory 8 as well as from other investigations 42, 43 and is considerably better than the 45% attendance rate reported during a 6-month exercise program in another report. 44 Our data indicate that patients with PAD who currently smoke adhere to a program of exercise just as well as their nonsmoking counterparts. Furthermore, a similar percentage of smokers (22%) and nonsmokers (18%) dropped out in the early phase of our exercise program, and none of the patients experienced serious adverse events that caused them to discontinue from the exercise program. The attrition rate of patients enrolled in this study is similar to that found in previous reports having a study duration between 3 and 6 months 7, 8, 45 and is considerably smaller than the 40% attrition rate that we found in a long-term exercise study lasting 18 months. 9 Collectively, data from this study indicate that patients with PAD who currently smoke are equally likely to attend and safely complete a supervised program of exercise as are their nonsmoking counterparts.
The nonsmoking patients with PAD increased their ICD by 194 meters (97%) and their ACD by 254 meters (59%) after 6 months of exercise rehabilitation, supporting previous reports from our laboratory. [6] [7] [8] [9] The smoking group demonstrated similar gains in ICD (191 meters; 119%) and in ACD (300 meters; 82%) after exercise rehabilitation, suggesting that concomitant cigarette smoking does not interfere with exercise-mediated improvements in claudication walking distances. This notion supports a previous investigation that found no significant correlation between the smoking habits at baseline and the 78% increase in ICD and the 61% increase in ACD in 51 patients with PAD who completed 6 months of exercise rehabilitation. 43 In addition to the improvements in ICD and ACD after exercise rehabilitation, the nonsmoking and smoking groups demonstrated similar exercise-mediated increases in peak oxygen uptake of 8% and 15%, respectively, as well as similar improvements in walking economy of 11% and 9%. The increase in peak oxygen uptake is supported by some 7,9-13 but not all investigations. 8, 46 The improvement in walking economy following a program of exercise rehabilitation, demonstrated by a reduced oxygen uptake to accomplish a given exercise task, supports previous investigations [7] [8] [9] [10] [11] 26 The combined improvements in peak oxygen uptake and walking economy indicate that both the nonsmoking and smoking groups were able to perform the submaximal walking test at only 69% of their peak oxygen uptake following exercise rehabilitation, compared with 84% and 88% at baseline, respectively. This is the first investigation to compare the changes in peak oxygen uptake and walking economy in smokers and nonsmokers following exercise rehabilitation, and the data suggest that patients with PAD who currently smoke can improve their cardiopulmonary function and their efficiency in walking to a similar extent as their nonsmoking counterparts.
The lower relative intensity of treadmill walking following exercise rehabilitation could have important implications in performing tasks that more closely approximate activities of daily living in the community setting. For example, both the smoking and nonsmoking patients experienced significant and similar improvements in the painfree walking distance and the total walking distance during the 6-minute walk test and in monitored daily physical activity in the community setting. These findings support previous investigations [7] [8] [9] and suggest that current smoking status has no effect on the improvements in ambulatory function and physical activity level following a program of exercise rehabilitation. From a clinical standpoint, these gains may be more meaningful for the smokers because their extreme sedentary lifestyle and greater ambulatory impairment at baseline places them at a higher risk of subsequent morbidity and mortality. 47, 48 The greater relative gains in ambulation and physical activity of the smokers translated into greater gains in their perceived ability to ambulate at various speeds and to climb stairs compared with their nonsmoking counterparts. The overall improvement in claudication pain and physical function following exercise rehabilitation resulted in similar gains in healthrelated measures of quality of life between the smokers and the nonsmokers. It is particularly interesting to note that a program of exercise rehabilitation improved specific domains in both physical health and mental health in patients with PAD with intermittent claudication regardless of smoking status. The exercise-mediated increase in the physical function domain is supported by previous investigations, 12, 13, 49, 50 as is the increase in bodily pain. 49 However, this is the first study to report improvements in mental health and vitality following exercise rehabilitation.
Both the smoking and nonsmoking patients had significant and similar increases in perfusion of the calf musculature following exercise rehabilitation, suggesting that enhanced peripheral circulation is a potential mechanism for the improvement in claudication pain distances and ambulatory function. Exercise-mediated increases in peripheral circulation, as measured by venous occlusion plethysmography, are supported by some [7] [8] [9] [10] but not in all studies. 46, 51 The decrease in the ischemic window in both groups following exercise rehabilitation lends further evidence of enhanced perfusion of the lower extremities and is supported by previous investigations. 7, 32 Collectively, these findings suggest that lower-extremity perfusion increases after a program of exercise rehabilitation in patients with PAD with intermittent claudication and that smokers experience the same hemodynamic improvements as their nonsmoking counterparts. The enhanced peripheral circulation may be due to improvements in nitric oxide-mediated endothelial function seen in patients with PAD after a program of exercise rehabilitation. 52 Although the results of this trial support the efficacy of exercise rehabilitation for patients with PAD regardless of their smoking status, several limitations exist. First, patients who participated in this trial were volunteers and, therefore, may represent those patients who were more interested in exercise, who had better access to transportation to the program, and who were in relatively better health than patients with PAD who did not volunteer. Second, the study participants were predominantly men. Consequently, the efficacy of exercise for both smokers and nonsmokers may not generalize to women limited by intermittent claudication. Finally, some bias in the study results could exist because the analyses were limited to only those patients who completed the study. Although there were no differences in baseline characteristics between the 85 patients who completed the trial and the 21 patients who withdrew (data not shown), the possibility that those patients who withdrew from the study would have responded less favorably to exercise cannot be ruled out.
SUMMARY AND CONCLUSIONS
In summary, the major findings of this investigation were (1) smokers had greater impairments in claudication pain distances, ambulatory function, physical activity, peripheral circulation, and health-related quality of life than did nonsmokers at baseline and (2) both groups had similar improvements in these measures following a 6-month exercise rehabilitation program. In conclusion, exercise rehabilitation is an effective therapy to improve functional independence in both smoking and nonsmoking patients with PAD limited by intermittent claudication. Smokers with intermittent claudication are prime candidates for exercise rehabilitation because their relatively low baseline physical function does not impair their ability to regain lost functional independence to levels similar to nonsmoking patients with PAD.
